Premium
BRONCHODILATOR EFFECT OF HEXOPRENALINE AEROSOL IN BRONCHIAL ASTHMA AND CHRONIC BRONCHITIS
Author(s) -
Schonell Malcolm,
Harris Margaret,
McMiken Donald,
Jenne Helen,
Evers Reinhard
Publication year - 1977
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.1977.tb99334.x
Subject(s) - bronchodilator , salbutamol , asthma , medicine , chronic bronchitis , anesthesia , bronchitis , bronchodilator agents , cardiology
The bronchodilator effects of aerosols of hexoprenaline (200 μg and 400 μg), and salbutamol (200 μg) were compared in 15 patients with asthma, and nine patients with chronic bronchitis. In both groups of patients, hexoprenaline and salbutamol produced a similar increase in the forced expiratory volume in one second (FEV 1 ), and mean percentage increase in FEV 1 . Neither drug caused tachycardia or arrhythmia. It was concluded that hexoprenaline aerosol was a safe and effective bronchodilator.